Detalhe da pesquisa
1.
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
Blood
; 143(13): 1231-1241, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38145560
2.
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study.
Lancet Oncol
; 25(4): 488-500, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547893
3.
Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.
Blood
; 139(17): 2706-2711, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134127
4.
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Blood
; 140(1): 16-24, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325065
5.
Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapy.
Cytotherapy
; 26(3): 261-265, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38149948
6.
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials.
Mol Ther
; 31(3): 801-809, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36518078
7.
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
Blood
; 137(19): 2585-2597, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270816
8.
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients.
Haematologica
; 108(7): 1840-1850, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36373249
9.
An International Society for Cell & Gene Therapy working group short report on the future of expanded access to unapproved cell and gene therapies.
Cytotherapy
; 25(7): 712-717, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097267
10.
International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.
Cytotherapy
; 25(9): 920-929, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37517865
11.
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.
Blood
; 132(22): 2351-2361, 2018 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262660
12.
In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas.
Mol Ther
; 26(12): 2727-2737, 2018 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30309819
13.
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma.
Mol Ther
; 25(9): 2214-2224, 2017 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28602436
14.
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation.
Blood
; 125(26): 4103-13, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25977584
15.
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene.
Blood
; 123(25): 3895-905, 2014 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24753538
16.
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation.
Blood
; 121(26): 5113-23, 2013 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-23610374
17.
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.
Blood
; 122(17): 2965-73, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24030379
18.
Inducible apoptosis as a safety switch for adoptive cell therapy.
N Engl J Med
; 365(18): 1673-83, 2011 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22047558
19.
Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for Neuroblastoma.
Res Sq
; 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38659815
20.
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers.
Res Sq
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38645165